Electrophysiologic testing identified an explanatory arrhythmia in all 7 symptomatic patients with hypertrophic cardiomyopathy, and guided therapy prevented symptom recurrence over 120 patient-months.
Observational (n=7)
Hypertrophic Obstructive Cardiomyopathy (n=7)
Electrophysiologic testing and guided antiarrhythmic therapy
Identification of an electrophysiologic abnormality explaining symptoms
Patients with hypertrophic obstructive cardiomyopathy are subject to syncope and sudden death. Ambulatory monitoring discloses frequent and complex ventricular ectopy in many of these patients, and the occurrence of ventricular tachycardia suggests an increased risk of sudden death. We prospectively evaluated whether induced sustained arrhythmia could explain episodes of cerebral dysfunction in hypertrophic cardiomyopathy. Seven consecutive symptomatic patients (six of whom had an intraventricular gradient of 40 to 130 mm Hg) were subjected to atrial and ventricular stimulation. An electrophysiologic abnormality that would explain the symptoms was identified in every patient: supraventricular tachycardia was present in two, sustained ventricular tachycardia in three, ventricular fibrillation in one, and a prolonged QT interval and dispersion of ventricular refractoriness in one. Antiarrhythmic drugs were selected on the basis of the response to electrophysiologic testing. There has been no recurrence of symptoms in 120 patient-months of follow-up. This experience suggests that arrhythmias are the principal cause of syncope or sudden death in obstructive cardiomyopathy and that electrophysiologic study may be useful in selecting prophylactic therapy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Peter R. Kowey
Lankenau Heart Institute
Richard R. Eisenberg
NewYork–Presbyterian Hospital
Toby Engel
Cooper University Hospital
New England Journal of Medicine
Philadelphia Fire Department
Building similarity graph...
Analyzing shared references across papers
Loading...
Kowey et al. (Thu,) conducted a observational in Hypertrophic Obstructive Cardiomyopathy (n=7). Electrophysiologic testing and guided antiarrhythmic therapy was evaluated on Identification of an electrophysiologic abnormality explaining symptoms. Electrophysiologic testing identified an explanatory arrhythmia in all 7 symptomatic patients with hypertrophic cardiomyopathy, and guided therapy prevented symptom recurrence over 120 patient-months.
synapsesocial.com/papers/6a08db7e73760a4edcd60490 — DOI: https://doi.org/10.1056/nejm198406143102405
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: